Regulatory considerations for Cellular Therapy
DOI:
https://doi.org/10.46765/2675-374X.2022v3n1p166Palavras-chave:
Regulatory; advanced therapy products; registration; good manufacturing practiceResumo
Advanced therapy products can be an alternative treatment for several disease. Manufacturing steps and product release are critical points to avoid unsafe use of products. Quality controls tests, manufacturing practice, safety testing and efficacy trials need to be properly accessed before releasing to patients. Regulatory system for cell therapy products determines guidelines for production, clinical trials and registration, considering risk-benefit ratios. This article aims to discuss main aspects of National Regulatory for advanced therapy products.
Downloads
Publicado
24/04/2022
Como Citar
Kondo, A. T., & Ribeiro, A. A. F. (2022). Regulatory considerations for Cellular Therapy. JBMTCT, 3(1), 166. https://doi.org/10.46765/2675-374X.2022v3n1p166
Edição
Seção
Artigos
Licença
Copyright (c) 2022 JBMTCT
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
